TipRanks
CF PharmTech. Inc. Class H (HK:2652)
:2652
Hong Kong Market
2652
CF PharmTech. Inc. Class H
RESEARCH TOOLSreports

CF PharmTech. Inc. Class H (2652) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2652 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
CF
PharmTech. Inc. Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2652 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:2652 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

2652 Financial Forecast

2652 Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

2652 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TFI Asset Management Analyst forecast on HK:2652
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
HK$38.22
Buy
171.26%
Upside
Reiterated
05/17/26
CF PharmTech. Inc. Class H (2652) Gets a Buy from TFI Asset Management
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TFI Asset Management Analyst forecast on HK:2652
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
HK$38.22
Buy
171.26%
Upside
Reiterated
05/17/26
CF PharmTech. Inc. Class H (2652) Gets a Buy from TFI Asset Management
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

2652 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
1
1
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
0
0
0
In the current month, 2652 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2652 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

2652 Stock Forecast FAQ

What is HK:2652’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:2652’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2652, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CF PharmTech. Inc. Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is CF PharmTech. Inc. Class H’s share price target?
      Currently, no data Available
      What do analysts say about CF PharmTech. Inc. Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CF PharmTech. Inc. Class H?
      To buy shares of HK:2652, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.